Corrigendum to “Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial” [Schizophr. Res. 157 (1–3) (August 2014) 112–119]
Titel:
Corrigendum to “Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial” [Schizophr. Res. 157 (1–3) (August 2014) 112–119]
Auteur:
Li, Huafang Luo, Jianfeng ChuanyueWang, Xie, Shiping Xu, Xiufeng XiaopingWang, Yu, Wenjuan Gu, Niufan Kane, John M.